Vioxx Label To Add Photosensitivity Reactions As Postmarketing Adverse Event
This article was originally published in The Pink Sheet Daily
Executive Summary
Supplemental NDA revises labeling for COX-2 inhibitor to include photosensitivity reactions. The Vioxx patient package insert will also be revised to include "skin reactions caused by sunlight."